Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -22.27% is 77% above its 5-year average of -95.88%, near the high end of its 5-year range (-189.74%–-16.12%).
78.36% above its 12-month average of -102.93%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -7.67%.
RETURN ON ASSETS (ROA)
-22.27%
RETURN ON ASSETS (ROA) AVG TTM
-102.93%
RETURN ON ASSETS (ROA) AVG 3Y
-118.23%
RETURN ON ASSETS (ROA) AVG 5Y
-95.88%
RETURN ON ASSETS (ROA) AVG 10Y
-112.85%
RETURN ON ASSETS (ROA) AVG 15Y
-92.04%
RETURN ON ASSETS (ROA) AVG 20Y
-80.52%
CURRENT VS TTM AVG
+78.36%
CURRENT VS 3Y AVG
+81.16%
CURRENT VS 5Y AVG
+76.77%
CURRENT VS 10Y AVG
+80.27%
CURRENT VS 15Y AVG
+75.80%
CURRENT VS 20Y AVG
+72.34%
SECTOR MEDIAN · HEALTHCARE
-31.37%
median of 781 covered companies
CURRENT VS SECTOR MEDIAN
+29.01%
vs the sector median at left
Microbot Medical Inc.
Market Cap
$50.08M
Return on Assets (ROA)
-22.27%
TTM Avg
-102.93%
3Y Avg
-118.23%
5Y Avg
-95.88%
Market Cap
$50.51M
Return on Assets (ROA)
-68.60%
TTM Avg
-124.17%
3Y Avg
-83.59%
5Y Avg
-65.75%
Market Cap
$50.45M
Return on Assets (ROA)
N/A
TTM Avg
-109.69%
3Y Avg
-346.56%
5Y Avg
-277.44%
Market Cap
$50.54M
Return on Assets (ROA)
-171.51%
TTM Avg
-144.24%
3Y Avg
-112.57%
5Y Avg
-82.33%
Market Cap
$50.11M
Return on Assets (ROA)
-44.77%
TTM Avg
-25.55%
3Y Avg
-81.14%
5Y Avg
-76.43%
Market Cap
$50.66M
Return on Assets (ROA)
-71.66%
TTM Avg
-64.58%
3Y Avg
-65.51%
5Y Avg
-55.75%
Market Cap
$50.73M
Return on Assets (ROA)
-162.93%
TTM Avg
-287.06%
3Y Avg
-300.16%
5Y Avg
-220.25%
Market Cap
$49.52M
Return on Assets (ROA)
-37.53%
TTM Avg
-1.93%
3Y Avg
9.94%
5Y Avg
4.69%
Market Cap
$51.38M
Return on Assets (ROA)
-49.54%
TTM Avg
-66.28%
3Y Avg
-54.88%
5Y Avg
-41.21%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $50.08M | -22.27% | -102.93% | -118.23% | -95.88% |
| INmune Bio, Inc. (INMB)vs › | $50.51M | -68.60% | -124.17% | -83.59% | -65.75% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.45M | N/A | -109.69% | -346.56% | -277.44% |
| Clene Inc. (CLNN)vs › | $50.54M | -171.51% | -144.24% | -112.57% | -82.33% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $50.11M | -44.77% | -25.55% | -81.14% | -76.43% |
| Celularity Inc. (CELU)vs › | $50.66M | -71.66% | -64.58% | -65.51% | -55.75% |
| Apollomics, Inc. (APLM)vs › | $50.73M | -162.93% | -287.06% | -300.16% | -220.25% |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.52M | -37.53% | -1.93% | 9.94% | 4.69% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.38M | -49.54% | -66.28% | -54.88% | -41.21% |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | -97.71% | -228.91% | -360.64% | -295.62% |
ROA
-22.3%
ROE
-23.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -16.12% |
| 2024-12-31 | -189.74% |
| 2023-12-31 | -128.98% |
| 2022-12-31 | -138.07% |
| 2021-12-31 | -67.47% |
| 2020-12-31 | -34.89% |
| 2019-12-31 | -19.52% |
| 2018-12-31 | -119.21% |
| 2017-12-31 | -68.87% |
| 2016-12-31 | -286.91% |
| 2015-12-31 | -171.62% |
| 2014-12-31 | -100.97% |
| 2013-12-31 | -63.62% |
| 2012-12-31 | -94.43% |
| 2011-12-31 | -84.62% |
| 2010-12-31 | -82.49% |
| 2009-12-31 | -52.80% |
| 2008-12-31 | -70.55% |
| 2007-12-31 | -51.83% |
| 2006-12-31 | -28.34% |
| 2005-12-31 | -26.18% |
| 2004-12-31 | -32.19% |
| 2003-12-31 | -62.12% |
| 2002-12-31 | -91.49% |
| 2001-12-31 | -16.56% |
| 2000-12-31 | -38.06% |
| 1999-12-31 | -99.54% |
| 1998-12-31 | -38.30% |
| 1997-12-31 | -40.86% |
| 1996-12-31 | -23.63% |
